Clinical Trials Logo

Clinical Trial Summary

This study is designed to compare the efficacy, acceptability, and safety of vaginal estrogen cream and platelet-rich plasma in pt. complaining of atrophic vaginitis.

Clinical Trial Description

Oestrogen deficiency affects many organs such as the genitourinary system. Genitourinary involvement causes untoward symptoms of atrophic vaginitis including dryness, burning, dyspareunia, vulvar pruritus, and discharge For this reason, many investigations have been performed to find out effective, safe, and acceptable therapeutic methods for atrophic vaginitis. Although systemic administration of estrogen can improve the localized symptoms of atrophic vaginitis, women are often reluctant to use systemic hormone replacement therapy and prefer local administration of estrogen. Vaginal application of estrogen has been considered an effective treatment of atrophic vaginitis. The effects of PRP treatment have been evaluated in many clinical conditions, including wound healing, hair repair, skin regeneration [9], vulvar lichen sclerosis, stress urinary incontinence, episiotomy scars, and lubrication aging in the vagina. It can take at least 12 weeks to determine the final effects of treatment with PRP Population of Study It includes 100 pt. complaining of atrophic vaginitis it will be divided into two groups, each group will contain 50 pt Methodology in detail: Patients of the first group will receive vaginal estrogen cream one tube every night for 14 nights; then, one tube 2 nights in 1 week (two tubes every week) for 10 weeks. The second group will receive PRP injection every 3 weeks for 4 times. PRP will be administered to the anterior vaginal wall using 27-G needles once every 3 weeks for 4 times and PRP is mainly injected into the clitoris or the anterior wall of the vagina to increase the tactile sensitivity of the injection site. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05118685
Study type Interventional
Source Fayoum University
Contact rehab A aboshama, lecturer
Phone 01156608221
Email [email protected]
Status Recruiting
Phase Phase 1
Start date November 13, 2021
Completion date May 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05058313 - Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy N/A
Active, not recruiting NCT00984399 - Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen N/A
Recruiting NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Terminated NCT00816556 - A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis Phase 3
Completed NCT00167921 - Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis Phase 1
Completed NCT04327947 - Evaluation of Gynecological Acceptability of 3 Health Care Products N/A
Completed NCT03294538 - Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Phase 3
Completed NCT02691936 - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy N/A
Completed NCT02195986 - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Phase 3
Recruiting NCT03981458 - Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis N/A
Completed NCT02869165 - Vaginal and Urinary Microbiome Trial Phase 4
Completed NCT02029053 - Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness Phase 0
Recruiting NCT02733731 - The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Phase 1
Recruiting NCT02460302 - Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy Phase 2
Completed NCT02313545 - Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV Phase 1/Phase 2
Recruiting NCT04219605 - Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions
Completed NCT00137371 - Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis Phase 3
Completed NCT04247022 - Evaluation of Gynecological Acceptability of a Health Care Product N/A
Completed NCT02995694 - A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis Phase 3
Completed NCT01370551 - Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients Phase 1